A proof of concept for structure-based vaccine design targeting RSV in humans

Crank, Michelle C., Ruckwardt, Tracy J., Chen, Man, Morabito, Kaitlyn M., Phung, Emily, Costner, Pamela J., Holman, LaSonji A., Hickman, Somia P. +43 more·2019·Science
DOI 10.1126/science.aav9033

Cited by (333)

Items 201–300 of 333

  1. New Approaches to Vaccinology Made Possible by Advances in Next Generation Sequencing, Bioinformatics and Protein modeling
    Amelia R. Woolums, Cypriana Swiderski · 2021 · Current Issues in Molecular Biology
  2. Vaccination and modern management of chronic obstructive pulmonary disease – a narrative review
    Oana Joean, Tobias Welte · 2022 · Expert Review of Respiratory Medicine
  3. Development of a High Yielding Bioprocess for a Pre-fusion RSV Subunit Vaccine
    Peifeng Chen, Mingzhong Chen, Amritha Menon, Althaf I. Hussain, Elizabeth Carey, Christopher Lee, Joe Horwitz, Sarah E. O’Connell, Johnathan W. Cooper, Richard Schwartz et al. · 2020 · Journal of Biotechnology
  4. Controlled Human Infection Challenge Studies with RSV
    Pete Dayananda, Christopher Chiu, Peter Openshaw · 2022 · Current topics in microbiology and immunology
  5. De novo protein design enables precise induction of functional antibodies in vivo
    Fabian Sesterhenn, Che Yang, Jaume Bonet, Johannes Cramer, Xiaolin Wen, Yimeng Wang, Chi-I Chiang, Luciano A. Abriata, Iga Kucharska, Giacomo Castoro et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  6. Biocompatible lipid nanovehicles for preventive and therapeutic vaccine development
    Yaru Jia, Ziran Zhou, Luksika Jiramonai, Jianxin Chen, Qian Hua, Mengliang Zhu, Jinchao Zhang, Xing‐Jie Liang · 2025 · Coordination Chemistry Reviews
  7. Post-marketing safety monitoring of RSV vaccines: A real-world study based on the Vaccine Adverse Event Reporting System (VAERS)
    Zhuocheng Bao, Weixi Gao, Yu Xiao, Liqing Chai, Yuxiang Liu · 2025 · Human Vaccines & Immunotherapeutics
  8. Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection
    Sarah M. Valencia, Eric Rochat, Melissa J. Harnois, Maria L. Dennis, Helen S. Webster, Bhavna Hora, Amit Kumar, Hsuan-Yuan Wang, Leike Li, Daniel C. Freed et al. · 2023 · npj Vaccines
  9. Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadth
    Katrina M. Pollock, Hannah M. Cheeseman, Leon R. McFarlane, Suzanne Day, Monica Tolazzi, Hannah L. Turner, Jennifer Joypooranachandran, Katsiaryna Shramko, Stefania Dispinseri, Philipp Mundsperger et al. · 2025 · EBioMedicine
  10. Identification of a DRB3*011:01-restricted CD4+ T cell response against bovine respiratory syncytial virus fusion protein
    Bryan S. Kaplan, Amelia Ruth Hofstetter, Jodi L. McGill, John D. Lippolis, Junzo Norimine, Rohana P. Dassanayake, Randy E. Sacco · 2023 · Frontiers in Immunology
  11. Calculating the Costs and Benefits of Advance Preparations for Future Pandemics
    Rachel Glennerster, Christopher M. Snyder, Brandon Joel Tan · 2023 · IMF Economic Review
  12. Advanced Live Attenuated Vaccines for the Prevention of Respiratory Syncytial Virus Infections in Young Children
    Octavio Ramilo, Rosa Rodríguez Fernández, Mark E. Peeples, Asunción Mejías · 2019 · The Journal of Infectious Diseases
  13. Cold-adapted influenza vaccine carrying three repeats of a respiratory syncytial virus (RSV) fusion glycoprotein epitope site protects BALB/c mice and cotton rats against RSV infection
    Yongru Xu, Fang Sun, Zhengran Chuai, Junyun Wang, Zhifang Bai, Chengrong Bian, Xiliang Wang, Zhongpeng Zhao, Yongzhuang Liu, Penghui Yang · 2024 · Antiviral Research
  14. The Input of Structural Vaccinology in the Search for Vaccines against Bunyaviruses
    Alexandra Serris · 2021 · Viruses
  15. Next-generation RSV vaccines avoid flipping out
    Mark E. Peeples · 2022 · Science Translational Medicine
  16. AB5-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus
    Jina Ahn, Ji Eun Yu, Hanna Kim, Jemin Sung, Gyoonhee Han, Myung Hyun Sohn, Baik Lin Seong · 2023 · Toxins
  17. Comparative analysis of human respiratory syncytial virus evolutionary patterns during the COVID-19 pandemic and pre-pandemic periods
    Chi-yu Guo, Yu Zhang, Y L Zhang, Wei Zhao, Xiang-Lei Peng, Yan-Peng Zheng, Yuan-Hui Fu, Jie‐mei Yu, Jinsheng He · 2023 · Frontiers in Microbiology
  18. Guiding the Immune Response to a Conserved Epitope in MSP2, an Intrinsically Disordered Malaria Vaccine Candidate
    Jeffrey Seow, Sreedam Chandra Das, Rodrigo A. V. Morales, Ricardo Ataíde, Bankala Krishnarjuna, Mitchell R. Silk, David K. Chalmers, Jack S. Richards, Robin F. Anders, Christopher A. MacRaild et al. · 2021 · Vaccines
  19. Progress in the Development of Structure-Based Vaccines
    Sunil Thomas, Ann Abraham · 2021 · Methods in molecular biology
  20. Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 – a review
    Christine M. Akamine, Hana M. El Sahly · 2021 · Translational research
  21. The Role of Vaccines in Combating Antimicrobial Resistance
    K. Jansen, W. Gruber, R. Simon, J. Wassil, Annaliesa S. Anderson · 2021 · Sustainable Agriculture Reviews
  22. Calculating the Costs and Benefits of Advance Preparations for Future Pandemics
    Rachel Glennerster, Christopher Snyder, Brandon Joel Tan · 2022 · National Bureau of Economic Research
  23. Self-assembled nanoparticle vaccine comprised of multiple epitopes provides robust protective immunity against reoviruses in fish model
    Feifan Xu, Zhao Zhao, Zhu‐Yang Deng, Jia-Lun Tang, Bin Zhu · 2025 · Cell Communication and Signaling
  24. Novel Strategies for Developing Next-Generation Vaccines to Combat Infectious Viral Diseases
    Fangfeng Yuan, Martin H. Bluth · 2025 · Vaccines
  25. Respiratory Syncytial Virus (RSV): A Comprehensive Overview From Basic Biology to Clinical Prevention and Control
    Jie Shi, Xiya Huang, Chunjun Ye, Yishan Lu, Yanyan Liu, Yuquan Wei, Xiawei Wei · 2025 · Medicinal Research Reviews
  26. An mRNA vaccine encoding multiple envelope glycoproteins of porcine reproductive and respiratory syndrome virus confers efficient protection against NADC30-like strains
    Haoran Zhou, Yangyang Sun, Lujie Zhang, Xiao Liang, Juan Bai, Yanni Gao, Ping Jiang · 2025 · International Journal of Biological Macromolecules
  27. Therapeutic targeting of Respiratory Syncytial Virus: Current pharmacological options and future directions in antiviral development
    Luisa Fernanda Ontiveros-Zúñiga, Sharon Itzel Sosa-Mondragon, Juan Fidel Osuna‐Ramos, Randy Seir Llanas-Vázquez, David Mauricio Cañedo-Figueroa, Manuel Adrián Velázquez-Cervantes, Kevin Paul Miranda-Lizárraga, Andrea Laredo-Cabrera, Luis Enrique Flores-Padilla, Giovanna Berenice Barrera-Aveleida et al. · 2026 · Microbiological Research
  28. In Silico Structure-Based Vaccine Design
    Sakshi Piplani, David Alan Winkler, Yoshikazu Honda‐Okubo, Varun Khanna, Nikolai Petrovsky · 2023 · Methods in molecular biology
  29. Cell-Based Relative Potency of a Respiratory Syncytial Virus mRNA Vaccine Correlates with In Vivo Immunogenicity
    Katrina Feller, Hesham F. Nawar, Liping Song, Amanda Abrams, Liang Shang, Ashley Gruber, Tatyana Yun, Hualin Helen Li · 2025 · Vaccines
  30. Pre-Clinical Development of an Adenovirus Vector Based RSV and Shingles Vaccine Candidate
    Lawrence J. Petherbridge, Charlotte Davis, Angela Robinson, T. Evans, S. Sebastian · 2023 · Vaccines
  31. Prophylaxis of respiratory syncytial virus infection: current status and prospects for vaccine development
    Коровкин Алексей Сергеевич, Горенков Дмитрий Витальевич, A R Volgin · 2024 · Biological Products Prevention Diagnosis Treatment
  32. Induction of neutralizing antibody responses by AAV5-based vaccine for respiratory syncytial virus in mice
    Guangxu Ma, Zeping Xu, Chinyu Li, Feng Zhou, Branda T. Hu, Junwei Guo, Changwen Ke, Liqing Chen, Guilin Zhang, Hungyan Lau et al. · 2024 · Frontiers in Immunology
  33. Replacing serum with dried blood microsampling for pharmacokinetics, viral neutralisation and immunogenicity bioanalysis supporting future paediatric development of RSM01, a candidate respiratory syncytial virus neutralising monoclonal antibody
    Joleen T. White, Jonne Terstappen, Micha Levi, Andrijana Radivojevic, Robert Noble, Aparna B. Anderson, Gwendolyn Wise-Blackman, Michael W. Dunne · 2024 · BMC Infectious Diseases
  34. Shot Through the Heart—Can RSV Vaccination Reduce Risk of Cardiovascular Outcomes?
    Helen Y. Chu, Alastair F. Murray · 2025 · JAMA
  35. Human respiratory syncytial virus F protein expressed in Pichia pastoris or Escherichia coli induces protective immunity without inducing enhanced respiratory disease in mice
    Hai Li, Lei Cao, Yan Zhang, Hu Ren, Peibei Zhao, Wenbo Xu · 2020 · Archives of Virology
  36. A molecular perspective for the development of antibodies against the human respiratory syncytial virus
    Ricardo A. Loaiza, Robinson A. Ramírez, Javiera Sepúlveda-Alfaro, Mario A. Ramírez, Catalina A. Andrade, Jorge A. Soto, Pablo A. González, Susan M. Bueno, Alexis M. Kalergis · 2023 · Antiviral Research
  37. The respiratory syncytial virus fusion protein-specific B cell receptor repertoire reshaped by post-fusion subunit vaccination
    Gerald Schneikart, Simona Tavarini, Chiara Sammicheli, Giulia Torricelli, Silvia Guidotti, Emanuele Andreano, Francesca Buricchi, Ugo D’Oro, Oretta Finco, Monia Bardelli · 2020 · Vaccine
  38. A bottom-up approach for the de novo design of functional proteins
    Che Yang, Fabian Sesterhenn, Jaume Bonet, Eva A. van Aalen, Leo Scheller, Luciano A. Abriata, Johannes Cramer, Xiaolin Wen, Stéphane Rosset, Sandrine Georgeon et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Respiratory Syncytial Virus: An Old Foe in a New Era
    Ann Regina Falsey, Edward E. Walsh · 2020 · The Journal of Infectious Diseases
  40. Rational design of respiratory syncytial virus dimeric F-subunit vaccines in protein and mRNA forms
    Jing Li, Xuehui Ma, Zepeng Xu, Wenjing Guo, Ruchao Peng, Yuqin Zhang, Yumin Meng, Jianrui Zhao, Qiyue Wang, Shuang Li et al. · 2025 · EBioMedicine
  41. Comparison of major, minor and junctional circumsporozoite protein epitopes for malaria vaccine design
    Emma C. Ryan, Dallas R. Brown, William Harrison, Shelby D. Foor, Kutub Ashraf, Jessica S. Bolton, Yevel Flores-García, Randall S. MacGill, Emily Locke, Elke S. Bergmann‐Leitner et al. · 2025 · npj Vaccines
  42. Functional and antigenic constraints on the Nipah virus fusion protein
    Brendan B. Larsen, Sheri Harari, Risako Gen, Cameron Stewart, David Veesler, Jesse D. Bloom · 2026 · Proceedings of the National Academy of Sciences
  43. Pneumoviruses: Respiratory Syncytial Virus and Human Metapneumovirus
    Jarrod J. Mousa, John V. Williams, James E. Crowe · 2022 · Springer eBooks
  44. Integrative Approaches to Study Virus Structures
    David Ian Stuart, Hanna M. Oksanen, Nicola G. A. Abrescia · 2024 · Sub-cellular biochemistry/Subcellular biochemistry
  45. Potent Cross‐neutralizing Antibodies Reveal Vulnerabilities of Henipavirus Fusion Glycoprotein
    Yi Ren, Pengfei Fan, Xinghai Zhang, Ting Fang, Zhengshan Chen, Yanfeng Yao, Xiangyang Chi, Guanying Zhang, Xiaofan Zhao, Bingjie Sun et al. · 2025 · Advanced Science
  46. Single-Dose Intranasal Immunization with ChAd68-Vectored Prefusion F Vaccines Confers Sustained Protection Against Respiratory Syncytial Virus in Murine Models
    Jing Miao, Xuejie Li, Yingwen Li, Lingjing Mao, Wenkai Suo, Jiaming Lan · 2025 · Vaccines
  47. Immunofocusing design of a fusion glycoprotein monomer vaccine for respiratory syncytial virus
    Qianqian Li, Zhiming Li, Jiamin Chen, Qiuju He, Hongjian Xiao, Haiwei Li, Huan Li, Heng Zhang, Yaoyun Yang, Rong Bi et al. · 2025 · Molecular Therapy
  48. Vaccine Design Informed by Virus-Induced Immunity
    Rhiannon R. Penkert, Jane Silva Hankins, Neal S. Young, Julia L. Hurwitz · 2020 · Viral Immunology
  49. Viral infections causing asthma exacerbations in the age of biologics and the COVID-19 pandemic
    Pedro A. Lamothe, Violeta Capric, Frances Eun-Hyung Lee · 2024 · Current Opinion in Pulmonary Medicine
  50. Entry of Enveloped Viruses into Host Cells: Membrane Fusion
    Vicente Más, José Antonio Melero · 2024 · Sub-cellular biochemistry/Subcellular biochemistry
  51. A Challenge to Respiratory Syncytial Virus Illness in Adults
    Marie R. Griffin · 2022 · New England Journal of Medicine
  52. T cell-mediated protection in absence of virus neutralizing antibodies
    Yeranddy Aguiar Alpizar, Kai Dallmeier · 2025 · Nature Microbiology
  53. Respiratory syncytial virus immunization in children: The old, the new and what’s just around the corner
    Bosco A Paes, Fabiana Bacchini, Marianne Bracht, Barry S. Rodgers‐Gray, Xavier Carbonell‐Estrany · 2025 · Human Vaccines & Immunotherapeutics
  54. Design of cross-reactive antigens with machine learning and high-throughput experimental evaluation
    Chelsy C. Chesterman, Thomas Desautels, L. F. Chaparro Sierra, Kathryn T. Arrildt, Adam T Zemla, Edmond Y. Lau, Shivshankar Sundaram, Jason P. Laliberte, Lynn Chen, Aaron Ruby et al. · 2025 · Frontiers in Bioinformatics
  55. Metavac-RSV mucosal bivalent vaccine candidate protects cotton rats against pneumoviruses and is produced using serum-free cell culture in bioreactor
    Caroline Chupin, Pauline Brun, Marjorie Ray, Chloé Mialon, MV Reitano, Aurélien Traversier, Emilie Laurent, Abdelghafar Goumaidi, Julien Fouret, Stéphane Paul et al. · 2025 · npj Vaccines
  56. Developing an eVLP mRNA vaccine for respiratory syncytial virus with enhanced pre-fusion targeting humoral responses
    Lei Sun, Mengting Huang, Simin Feng, Wei Zhang, Yun Quan, Ruyi Chen, Yupeng Yang, Haidong Xu, Wansheng Li, Qianyu Pan et al. · 2025 · Journal of Virology
  57. Structures of CRP antigen-antibody complexes provide insights into the mechanism of specific recognition
    Yijian Li, Qianxi Yu, Mengtan Du, Jian Zhang, Tonggong Liu, Jingzhe Wang, Qingchun Wei, Yong Peng, Chaohui Duan, Dayong Gu et al. · 2025 · Communications Biology
  58. Discovery and molecular mechanism of potent neutralizing antibody from humanized mice with respiratory syncytial virus
    Zheng Zhang, Rui Feng, Long Zhang, Qi Yang, Xuehua Chen, Xiaoxiao Wang, Cui Nie, Wei Peng, Xiangxi Wang, Ling Zhu et al. · 2025 · PLoS Pathogens
  59. Transplacental transfer of antibodies against pertussis and respiratory syncytial virus and follow-up after birth
    Yukako Kosaka, Takashi Ito, Kyoko Hattori, Ayumi Saito, Yusuke Okuda, Daigo Ochiai, Kenji Ishikura, Kazuhiko Katayama, Tetsuo Nakayama · 2025 · Journal of Infection and Chemotherapy
  60. Isolation and characterization of broadly-neutralizing anti-HCMV-gB antibodies from human donors using a prefusion-stabilized HCMV gB variant
    Maria Krasilnikov, Yu-Hsin Wan, Ellen M. White, Beatriz Gálvez-Martínez, Mohammad Karimian Shamsabadi, Nicholas T. Aldridge, Bibhav Poudel, Adrian W. Sperl, Andrew McGuire, Ekaterina E. Zheleznova Heldwein · 2026 · PLoS Pathogens
  61. The impact of maternal respiratory syncytial virus vaccination on infant and perinatal outcomes: a systematic review and meta-analysis of randomized controlled trials
    Jonathan Rodrigues Lopes, Inês Martins Esteves, Sofia Oliveira Dias, Fernanda Andrade Silva, Gabrielle Catherine Dias Mafra da Silva, Natália Botelho Libonati, Regina Melittio Gasparetti, Angélica Luciana Nau · 2026 · Journal of Perinatology
  62. Structural Advances in Respiratory Syncytial Virus: Implications for Vaccine and Antiviral Development
    Xuanwei Huang, Caner Akıl, Peijun Zhang · 2026 · Microorganisms
  63. Intranasal DNA nanocarrier vaccines with surface-patterned antigens enhance efficacy against respiratory syncytial virus
    Xia Gao, Liting Chen, Qingqing Feng, Wei Lv, Peijun Xu, Zetao Yu, X G 晓光 Wang 王, Qinyi Zhang, Tianyu Shao, Yichao Lu et al. · 2026 · Nature Materials
  64. Protein engineering: status report
    Hui‐wang Ai, Frances H. Arnold, Doug Barrick, Hagan Bayley, Alfie-Louise R. Brownless, Robert E. Campbell, Roger Castells‐Graells, Pimchai Chaiyen, Roberto A. Chica, Lauren O. Chisholm et al. · 2026 · Protein Engineering Design and Selection
  65. Adjuvanted Vaccine to Prevent Respiratory Syncytial Virus in Adults Ages 60 Years and Older
    Annmarie Gennattasio · 2024 · Nursing for Women s Health
  66. Development and evaluation of vaccination strategies for addressing the continuous evolution SARS-CoV-2 based on recombinant trimeric protein technology: Potential for cross-neutralizing activity and broad coronavirus response
    Peng Fei Du, Ning Li, Shengjun Tang, Zhongcheng Zhou, Zhihai Liu, Taorui Wang, Jiahui Li, Simiao Zeng, Juan Chen · 2024 · Heliyon
  67. Inno4Vac Workshop Report Part 2: RSV‐Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK
    Joanna Waldock, Rebecca Jane Cox, Othmar G. Engelhardt, Stephanie Ascough, Albert D. M. E. Osterhaus, Guus F. Rimmelzwaan, Martin Ludlow, John S. Tregoning, Jacqueline U. McDonald, Ursula J. Buchholz et al. · 2024 · Influenza and Other Respiratory Viruses
  68. A Chimeric Virus-Like Particle Vaccine Presenting an Immunodominant Epitope of gB Elicited Potent Neutralizing Antibodies against EBV Infection In Vitro and In Vivo
    Ling Zhong, Wanlin Zhang, Rui Xiao, Huiping He, Qian Wu, Junping Hong, Mu‐Sheng Zeng, Qinjian Zhao, Qingbing Zheng, Yixin Chen et al. · 2025 · ACS Applied Materials & Interfaces
  69. Vaccination of a CdrA fragment conferred protection against Pseudomonas aeruginosa in wound infection via inhibition of biofilm formation
    Jiqing Wan, Meilin Wu, Zifan Zhu, Xinglong Liu, Junyi Li, Zhengzheng Wu, Yuhang Li, Yueyue Zhang, Yi Zhang, Ying Wang et al. · 2025 · Vaccine
  70. Respiratory Syncytial Virus Prevention in the Adult Population: State of the Art
    Tommaso Bigoni, Franco Alfano, Francesca Aloe, Federico Baraldi, Francesco Paolo Caggiano, Olga Dell'Adami de Tarczal, Alberto A. Papi · 2025 · Seminars in Respiratory and Critical Care Medicine
  71. Vaccines from the perspective of a pharmacist
    Aleš Franc · 2020 · Česká a slovenská farmacie
  72. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): Epidemiology and Vaccinology in Nigeria
    Ridwan Olamilekan Adesola, Oluwatobi Emmanuel Oladele, Ahmed Oluwasegun Tajudeen, Oluwatobi Ogundepo, M. Dinesh · 2021 · International Journal of Travel Medicine and Global Health
  73. The protective immunity induced by intranasally inoculated serotype 63 chimpanzee adenovirus vector expressing human respiratory syncytial virus prefusion fusion glycoprotein in BALB/c mice
    Lei Huang, Meiqing Liu, Chang-Qing Wan, Ningning Cheng, Yan-Bin Su, Yan-Peng Zheng, Xiang-Lei Peng, Jie‐mei Yu, Yuan-Hui Fu, Jinsheng He · 2022 · Frontiers in Microbiology
  74. THE GORDON WILSON LECTURE: RAPID COVID-19 VACCINE DEVELOPMENT AND THE FUTURE OF VACCINOLOGY.
    Barney S. Graham · 2023 · PubMed Central
  75. Vaccines against respiratory syncytial virus
    Emil Dariush Lichscheidt, Zitta Barrella Harboe, Thea Kølsen Fischer, Carsten Schade Larsen · 2024 · Ugeskrift for Læger
  76. Structure of endogenous Pfs230:Pfs48/45 in complex with potent malaria transmission-blocking antibodies
    Ezra T. Bekkering, Randy Yoo, Sophia Hailemariam, Fabian Heide, Danton Ivanochko, Matthew J. Jackman, Nicholas I. Proellochs, Rianne Stoter, Geert-Jan van Gemert, Ayana Maeda et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Progress Toward Antigenic Epitopes of African Swine Fever Virus and Their Identification
    Xingjun Ke, Zhi Cao, Zhen Weng, Yin Xie, WU Fengyu, Xinzhu Liu, Shiying Zhou, Mengjie Lian, Tongyu Liu, Ruize Sun et al. · 2025 · Transboundary and Emerging Diseases
  78. Chlamydia muridarum mutant CM-pGP3S as a novel attenuated live rectal vaccine protects against genital tract infection
    Jingyue Ma, Tianyuan Zhang, Qi Tian, Meng Xiao, Long Han, Quanzhong Liu, Guangming Zhong, Yuanjun Liu · 2025 · Frontiers in Cellular and Infection Microbiology
  79. Virus-like particles containing the extracellular domain of G protein in combination with a CTL peptide of M2 elicit protection against respiratory syncytial virus infection without pulmonary disease
    Huan Qin, Jin Luo, Zishu Pan · 2025 · Frontiers in Immunology
  80. Composition, stabilization and delivery of virus-based vaccines: considerations to break free of the cold chain
    Amaka J Epoh, Jailen H. Doyle, Irnela Bajrovic, Maria A. Croyle · 2025 · Advanced Drug Delivery Reviews
  81. Age-specific antibody profiles of respiratory syncytial virus after COVID-19 pandemic: a sero-epidemiological survey in Taizhou City, Eastern China
    Bo Zheng, Qiang Wang, Kathy S. M. Leung, Hongbiao Liang, Weiwei Shen, Mengting Cao, Suyi Zhang, Ye Wu, Haijiang Lin, Weibing Wang · 2025 · BMC Infectious Diseases
  82. Corrected and republished from: “Clinical validation of an RSV neutralization assay and analysis of cross-sectional sera associated with 2021–2023 RSV outbreaks to investigate the immunity debt hypothesis”
    Eli A. Piliper, Jonathan C. Reed, Alexander L. Greninger · 2025 · Microbiology Spectrum
  83. IgPose: a generative data-augmented pipeline for robust immunoglobulin–antigen binding prediction
    Tien-Cuong Bui, Injae Chung, Wonjun Lee, Junsu Ko, Juyong Lee · 2026 · Bioinformatics
  84. Immunodominance is a poor predictor of vaccine-induced T follicular helper cell quality
    Ming Z. M. Zheng, Hyon‐Xhi Tan, Kathleen M. Wragg, Lydia Murdiyarso, Devaki Pilapitiya, Andrew Kelly, Robyn Esterbauer, Christopher A. Gonelli, Adam K. Wheatley, Jennifer A. Juno · 2026 · EBioMedicine
  85. A first-in-human Phase 1/1b randomized trial evaluating the safety and immunogenicity of a respiratory syncytial virus (RSV) virus-like particle subunit vaccine (IVX-121) in healthy young and older adults
    Ilse De Coster, Isabel Leroux‐Roels, Kanchanamala Withanage, Leen Suykens, Valentino D’Onofrio, Geert G Leroux-Roels, Pierre Van Damme, Max Ciarlet, Elizabeth M. Adams, WASIMA N. RIDA et al. · 2026 · Human Vaccines & Immunotherapeutics
  86. Combination mRNA Vaccine Adjuvanted with CpG Oligodeoxynucleotides Enhances Protection against Respiratory Virus Infection
    Lingyan Cui, Sibo Zhang, Yarong Zeng, Limin Zhang, Min Lin, Minqing Hong, Huiqing Chen, Hong Wang, Wenhui Xue, Miaolin Lan et al. · 2026 · ACS Nano
  87. Human enterotoxigenic Escherichia coli (ETEC) infections elicit antibodies that broadly neutralize mucinases of pathogenic Escherichia coli and Shigella
    David P. Buckley, Marjahan Akhtar, Mahima Thapa, Aaron J. Schmitz, Jackson S. Turner, Tim J. Vickers, Nazia Khatoon, M. Hasanul Kaisar, Jonathan Coggin, Debayan Ganguli et al. · 2026 · Proceedings of the National Academy of Sciences
  88. Rational design 2.0: transitioning from static structural biology to computational prioritization and iterative vaccine optimization for RSV
    韦秀龙, Jing Chen, Z Y Li · 2026 · Frontiers in Immunology
  89. Rational design of an optimized ferritin nanoparticle vaccine targeting both SARS-CoV-2 and MERS-CoV
    Yaoming Liu, Haiyue Rao, Nana Wang, Xiaoqing Liu, Tao Chen, Bin Zhang, Jintao Lai, Jianyu Shan, Shiqi Xiao, Haojie Peng et al. · 2026 · Journal of Nanobiotechnology
  90. An Overview: the types of Covid-19 vaccines in Iraq
    Hiba Jasim Hamza, Raoof Jabbar Maaroof, Nada Khazal Kadhim Hindi, Ammar Abbas Shalan, Amean A. Yasir · 2022 · Journal of University of Babylon for Pure and Applied Sciences
  91. Clinical Trials in the Development of Vaccines for Infectious Diseases
    S. Lockhart, William C. Gruber · 2022 · Royal Society of Chemistry eBooks
  92. A Candidate DNA Vaccine Encoding the Native SARS-CoV-2 Spike Protein Induces Anti-Subdomain 1 Antibodies
    Anders Frische, Vithiagaran Gunalan, Karen Angeliki Krogfelt, Anders Fomsgaard, Ria Lassaunière · 2023 · Vaccines
  93. RNA therapeutics for infectious diseases
    Le Minh Tu Phan; Phan Le Minh Tu, Thi Thuy Duong Pham, Van Thai Than · 2024 · Progress in molecular biology and translational science
  94. Mammalian Antigen Display for Pandemic Countermeasures
    Andrea Quezada, Ankur Annapareddy, Kamyab Javanmardi, John Cooper, Ilya J. Finkelstein · 2024 · Methods in molecular biology
  95. Harnessing immunotherapeutic molecules and diagnostic biomarkers as human-derived adjuvants for MERS-CoV vaccine development
    Abdullah R. Alrasheed, Maaweya Awadalla, Hadeel Alnajran, Mohammed H. Alammash, Adil Mohammad Almaqati, Ishtiaq Qadri, Bandar Alosaimi · 2025 · Frontiers in Immunology
  96. mRNA疗法的研究进展与挑战
    Jiayan Fu, Shuo Feng, Binhe Du, Haiyang Dong, Jinzhong Lin, Jin Yongfeng · 2021 · Scientia Sinica Vitae
  97. TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines
    Irene Rivero Calle, José Gómez Rial, Louis Bont, Bradford D. Gessner, Melvin A. Kohn, Ron Dagan, Daniel C. Payne, Laia Bruni, Andrew John Pollard, Adolfo García‐Sastre et al. · 2020 · Human Vaccines & Immunotherapeutics
  98. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines
    Leonard Moise, Ted M. Ross, Daniel Fredric Hoft, William D Martin, Anne Searls De Groot · 2020 · Expert Review of Vaccines
  99. Profilaxia specifică a infecției cu SARS-COV-2, între clasic și modern | [Specific prophylaxis of SARS-COV-2 infection, between classical and modern]
    Elena Mihaela Constantinescu, Cristian-Adrian Constantinescu · 2022 · Jurnal Medical Brasovean
  100. Structural characterization of a cross-protective natural chimera of factor H binding protein from meningococcal serogroup B strain NL096
    Daniele Veggi, E. Malito, Paola Lo Surdo, Werner Pansegrau, Valentina Rippa, Newton Wahome, Silvana Savino, Vega Masignani, Mariagrazia Pizza, Matthew J. Bottomley · 2022 · Computational and Structural Biotechnology Journal